Telomerase and telomeres
Studied in cell cultures for effects on the ends of chromosomes.
Investigational · not FDA-approved
Educational information about an investigational peptide that is not FDA-approved: research, limits, risks and regulatory status.
Introduction
Epithalon is a synthetic peptide often promoted for healthy aging. This page explains what it is, what has been studied, what has and has not been shown in people, and its regulatory status.
Epithalon is not an FDA-approved medicine, and it has not been shown to slow aging or extend life in people.
Overview
Epithalon (also spelled epitalon) is a synthetic peptide made of four amino acids. It was designed in Russia based on epithalamin, an extract of the pineal gland. It is not melatonin and is not part of melatonin: melatonin is a hormone made by the pineal gland, but it is not a peptide.
Mechanisms
These are research topics, mostly in laboratory and animal studies, not proven effects.
Studied in cell cultures for effects on the ends of chromosomes.
Explored for effects on melatonin rhythms.
Examined in laboratory and animal models.
Aging research
Some animal studies, mainly from one research group in Russia, reported longer lifespan in rodents and insects, and laboratory studies reported changes in cell aging markers. Changes in these markers do not show that a person will age more slowly or live longer.
Next step
If you have questions about healthy aging, sleep or well-being, a medical evaluation helps identify proven options.
Evidence
Small, mostly in older adults, from a single research group.
Results have rarely been confirmed by other groups.
Benefits have not been tested in large, well-designed trials.
Long-term effects have not been studied.
Preclinical vs. human
Results in cells and animals often do not translate to people. Cellular repair, antioxidant protection, better sleep and longer life have not been established as clinical results of Epithalon in people.
Regulatory status
Epithalon is not approved by the FDA for any use. The FDA has raised safety concerns about its use in compounded drugs, and its eligibility for compounding was under review in 2026. An advisory committee recommendation is not an FDA approval.
Risks
Side effects have not been well characterized in large studies.
Redness, swelling or itching.
Reported informally.
Reported informally.
Purity and content can vary between sources.
Unknown, given its proposed effects on telomerase.
Not known.
Safety
Epithalon may not be appropriate, and should be discussed with a provider first, if any of the following apply to you:
Evaluation
Health history, medications and what you hope to achieve.
Causes are evaluated and treated with established care.
Prevention, screening, activity, nutrition and sleep.
FAQ
Clear answers to help you prepare.
No. Epithalon is not approved by the FDA for any use.
This has not been shown in people. Longer lifespan has been reported only in some animal studies.
No. Epithalon is a synthetic peptide; melatonin is a different hormone and is not a peptide.
This has not been established. Sleep problems have many causes that a medical evaluation can identify and treat.
This page is educational. It does not give doses, schedules or instructions; any decision about a medicine is made only by a licensed provider after an individual evaluation.
Information on this page is educational and does not replace medical evaluation. Treatment options are determined individually.